[Federal Register: December 16, 2003 (Volume 68, Number 241)]
[Notices]               
[Page 70021]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16de03-57]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Preparation of Radiolabeled Materials.
    Date: December 19, 2003.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: C. Michael Kerwin, Ph.D., MPH Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8057, MSC 8329, Bethesda, MD 20892-8329, 301-496-7421, kerwinm@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistant Program Nos. 93.392, Cancer 
Construction; 93.393, Cancer Cause and Prevention Research; 93.394, 
Cancer Detection and Diagnosis Research; 93.395; Cancer Treatment 
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers 
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, 
National Institutes of Health, HHS)

    Dated: December 10, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-30981 Filed 12-15-03; 8:45 am]

BILLING CODE 4140-01-M